High-risk prostate cancer—classification and therapy
AJ Chang, KA Autio, M Roach III, HI Scher - Nature reviews Clinical …, 2014 - nature.com
Approximately 15% of patients with prostate cancer are diagnosed with high-risk disease.
However, the current definitions of high-risk prostate cancer include a heterogeneous group …
However, the current definitions of high-risk prostate cancer include a heterogeneous group …
Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology
JP Droz, M Aapro, L Balducci, H Boyle… - The lancet …, 2014 - thelancet.com
Summary In 2010, the International Society of Geriatric Oncology (SIOG) developed
treatment guidelines for men with prostate cancer who are older than 70 years old. In 2013 …
treatment guidelines for men with prostate cancer who are older than 70 years old. In 2013 …
Accelerating histopathology workflows with generative AI-based virtually multiplexed tumour profiling
Understanding the spatial heterogeneity of tumours and its links to disease initiation and
progression is a cornerstone of cancer biology. Presently, histopathology workflows heavily …
progression is a cornerstone of cancer biology. Presently, histopathology workflows heavily …
Early salvage radiotherapy following radical prostatectomy
Context Depending on the pathologic tumour stage, up to 60% of prostate cancer patients
who undergo radical prostatectomy will develop biochemical relapse and require further …
who undergo radical prostatectomy will develop biochemical relapse and require further …
The role of magnetic resonance imaging in the diagnosis and management of prostate cancer
Background The diagnosis of prostate cancer has long been plagued by the absence of an
imaging tool that reliably detects and localises significant tumours. Recent evidence …
imaging tool that reliably detects and localises significant tumours. Recent evidence …
The role of robot-assisted radical prostatectomy and pelvic lymph node dissection in the management of high-risk prostate cancer: a systematic review
B Yuh, W Artibani, A Heidenreich, S Kimm, M Menon… - European urology, 2014 - Elsevier
Context The role of robot-assisted radical prostatectomy (RARP) for men with high-risk (HR)
prostate cancer (PCa) has not been well studied. Objective To evaluate the indications for …
prostate cancer (PCa) has not been well studied. Objective To evaluate the indications for …
Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi …
Background Long-term cancer control outcomes in clinically high-risk prostate cancer (PCa)
patients treated with robot-assisted radical prostatectomy (RARP) remain unknown …
patients treated with robot-assisted radical prostatectomy (RARP) remain unknown …
Ten-and 15-yr prostate cancer-specific mortality in patients with nonmetastatic locally advanced or aggressive intermediate prostate cancer, randomized to lifelong …
SD Fosså, F Wiklund, O Klepp, A Angelsen, A Solberg… - European urology, 2016 - Elsevier
Background In high-risk prostate cancer (PCa), no study with observation times beyond 10
yr has demonstrated survival improvement after addition of prostatic radiotherapy (RAD) to …
yr has demonstrated survival improvement after addition of prostatic radiotherapy (RAD) to …
MRI displays the prostatic cancer anatomy and improves the bundles management before robot-assisted radical prostatectomy
Objectives: To evaluate the impact of multiparametric magnetic0 resonance imaging
(mpMRI) to guide the nerve-sparing (NS) surgical plan in prostate cancer (PCa) patients …
(mpMRI) to guide the nerve-sparing (NS) surgical plan in prostate cancer (PCa) patients …
Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks …
BACKGROUND: Survival after surgical treatment using competing-risk analysis has been
previously examined in patients with prostate cancer (PCa). However, the combined effect of …
previously examined in patients with prostate cancer (PCa). However, the combined effect of …